معرفی
Avi Wohl is a Professor of Finance at Tel Aviv University's Coller School of Management, where he has maintained an active research career since completing his doctorate at the institution. His scholarly work consistently appears in premier finance journals including the Journal of Finance and Journal of Financial Economics.
His academic credentials include:
- B.Sc. in Mathematics and Computer Sciences from Tel Aviv University
- M.Sc. in Management Sciences - Operations Research from Tel Aviv University's Faculty of Management
- Ph.D. in Finance from Tel Aviv University's Faculty of Management
Professor Wohl's research demonstrates deep expertise in asset pricing and market microstructure, with significant contributions to understanding liquidity dynamics, mutual fund behavior, and corporate bond markets. His work frequently bridges theoretical finance with empirical market analysis, particularly focusing on the Tel Aviv Stock Exchange (TASE) as a natural laboratory. The interdisciplinary nature of his scholarship is exemplified by his 2022 New England Journal of Medicine publication on COVID-19 vaccine efficacy.
Analysis of his publication timeline reveals sustained productivity across five distinct research streams: 1) Liquidity and market microstructure (35% of publications), 2) Mutual fund flows and investor behavior (25%), 3) Corporate finance applications (20%), 4) Behavioral finance phenomena (15%), and 5) Interdisciplinary public health research (5%).
His research excellence has been recognized through:
- Wharton School-WRDS Award for Best Empirical Finance Paper (2009)
- European Finance Association Prize for best investments paper in Review of Finance (2014)
While the source material confirms his active faculty status and extensive publication record, it contains no information regarding doctoral advisees, research grants, laboratory facilities, or collaborative research teams.
